AZD7325

Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial

AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)

AZD7325 Japan Multiple Ascending Dose (MAD) Study

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.

Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

AZD7325 Multiple Ascending Dose Study

Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325

Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users

AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects

Determine the Effect of Multiple Doses of AZD7325, CYP Study

Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325